CD68 and atrial fibrillation: Treatment with resolvin-D1 significantly attenuated proarrhythmic remodeling and reduced the inducibility of AF which was accompanied by significant reduction of CD68+ macrophages and an increase of CD206+ macrophages in the heart (Hiram et al., 2021).